Sanofi India Limited Financial Ratios
SANOFI · Healthcare · Current price ₹2,942.1
P/E ratio
20.7x
P/B ratio
9.1x
ROE
43.6%
ROCE
59.6%
Debt / Equity
0.00
Dividend yield
2.4%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 20.7x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 9.1x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 43.6% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 59.6% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.00 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Sanofi India Limited's latest numbers.
Sanofi India Limited profitability
Sanofi India Limited generates a return on equity of 43.6% and a return on capital employed of 59.6%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.00 and a P/E of 20.7x, Sanofi India Limited is conservatively financed. Our overall business-quality score for the company is 7.3 / 10.
Understand the ratios
More on Sanofi India Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.